Nexaar, also known as sorafenib, was deeloped by Onyx Pharmaceuticals, a California biotechnology company, and Bayer, the German pharmaceutical company.

• Nexaar也叫sorafenib，由一家加州名为Onyx制药的生物技术公司和德国拜尔（Bayer）制药公司研发。